Loading data for GLMD — first visit, this takes a few seconds.
Eocene Ltd. (GLMD)
NasdaqCM: GLMD
· 实时价格 · USD
4.63
+0.80 (20.89%)
收盘价: Sep 09, 2026, 8:00 PM
股价、关键数字和最新消息,都在这一页。
Eocene Ltd.(GLMD)股价、分析与数据
暂无数据
| 买价 | 2.66 |
| 市值 | 4.95M |
| 营收(TTM) | n/a |
| 净利润(TTM) | -11.3M |
| 0.67 | |
| -14.29 | |
| n/a | |
| -4.5 | |
| 市净率(TTM) | 0.27 |
| 市销率(TTM) | 0.00 |
| 财报日期 | n/a |
| 卖价 | 5.05 |
| 成交量 | 301,155 |
| 20日均量 | 61,906 |
| 开盘价 | 3.91 |
| 前收盘价 | 3.83 |
| 日内区间 | 3.82 - 4.63 |
| 52周区间 | 3.29 - 13.20 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | n/a |
| 除息日 | n/a |
关于 GLMD
Eocene Ltd. a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications. The company develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in a Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluate...
公司完整简介财报意外
Eocene 已于 Sep 2, 2026 发布季度财报:
- 营收为 $0 低于预期 $0, , NaN% 同比增长.
- 每股收益为 -2.86 超出预期 0.26, , 43.25% 同比增长.
9月前 · Associated Press Finance
BC-Most Active StocksHIVE Digital Technologies Ltd. 30,450,329 3.7899